| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702237 | Practical Radiation Oncology | 2017 | 7 Pages |
Abstract
This study represents the largest cohort of endometrial cancer patients with extended follow-up receiving adjuvant IMRT. High rates of pelvic disease control and limited late toxicities demonstrate safety and efficacy of this approach in the setting of extended follow-up.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Siping BS, Beant S. MD, Dwight E. MD, MBA, FACRO, FACR, Joseph L. MD, Paniti MD, Alexander B. MD, Robert P. MD, John MD, Sushil MD,